Impel NeuroPharma Inc.

Great News! Now you can buy fractional shares of Impel NeuroPharma Inc.

What is Fractional Shares?

Fractional shares are pieces of one full share of a company or exchange-traded fund (ETF).

In INDmoney, you can buy Impel NeuroPharma Inc. stock in any dollar amount, or any other stock you want.

$10

$50

$100

IMPL

Impel NeuroPharma Inc. (IMPL)

Q: What is Impel NeuroPharma Inc. (IMPL) share price today?

Impel NeuroPharma Inc. (IMPL) share price today is $8.52

Q: Can Indians buy Impel NeuroPharma Inc. (IMPL) shares?

Yes, Indians can buy Impel NeuroPharma Inc. (IMPL) shares. As per RBI rule, an Indian citizen can invest 250,000 dollars a year in foreign markets.

Q: How can I buy Impel NeuroPharma Inc. (IMPL) shares from India?

Three ways to invest in Impel NeuroPharma Inc. (IMPL) stocks from India are 1.Investment through apps: INDmoney is one of the leading apps that help you invest in Impel NeuroPharma Inc. (IMPL) stocks from India 2.Investment through Indian brokers tied up with a foreign broker 3.Investment by opening an account with a Foreign broker

Q: Can Fractional shares of Impel NeuroPharma Inc. (IMPL) be purchased?

You can buy just a fraction of Impel NeuroPharma Inc. (IMPL) shares.

Q: What are the documents required to start investing in Impel NeuroPharma Inc. (IMPL) stocks?

You will need a proof of Identification (PAN, Aadhaar etc) and proof of address (Aadhaar, Voter ID etc) to invest in Impel NeuroPharma Inc. (IMPL) stocks . The entire process is paperless and can be completed seamlessly.

$8.523.9%▲

Key Stats

Open	$8.7
Today Low/High	$8.3 / $8.7
52 Week Low/High	$6.89 / $34.75
Market Cap	$188.92M

Company Details

Impel NeuroPharma, Inc. is a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for people suffering from diseases with high unmet needs, with an initial focus on diseases of the CNS. The Company’s strategy is to rapidly advance its product candidate pipeline that pairs its proprietary Precision Olfactory Delivery (POD®) system with well-established therapeutics, including TRUDHESA™ for the acute treatment of migraine, INP105 for the acute treatment of agitation and aggression in patients with autism, and INP107 for OFF episodes in Parkinson’s disease.